These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7813271)

  • 1. Nonbronchodilator effects of pirbuterol and ipratropium in chronic obstructive pulmonary disease.
    Ashutosh K; Dev G; Steele D
    Chest; 1995 Jan; 107(1):173-8. PubMed ID: 7813271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticholinergic versus beta 2-agonist on gas exchange in COPD: a comparative study in 15 patients.
    Pillet O; Manier G; Castaing Y
    Monaldi Arch Chest Dis; 1998 Feb; 53(1):3-8. PubMed ID: 9632900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled formoterol versus ipratropium bromide in chronic obstructive pulmonary disease.
    Chhabra SK; Vijayan VK; Vasu T
    Indian J Chest Dis Allied Sci; 2006; 48(2):97-102. PubMed ID: 16696522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter study of nebulized bronchodilator solutions in chronic obstructive pulmonary disease.
    Friedman M
    Am J Med; 1996 Jan; 100(1A):30S-39S. PubMed ID: 8610715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of inhaled dry powder ipratropium bromide on recovery from exercise of horses with COPD.
    Duvivier DH; Bayly WM; Votion D; Vandenput S; Art T; Farnir F; Lekeux P
    Equine Vet J; 1999 Jan; 31(1):20-4. PubMed ID: 9952325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of salmeterol on arterial blood gases in patients with stable chronic obstructive pulmonary disease. Comparison with albuterol and ipratropium.
    Khoukaz G; Gross NJ
    Am J Respir Crit Care Med; 1999 Sep; 160(3):1028-30. PubMed ID: 10471636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of higher than standard doses of salbutamol and ipratropium on tiotropium-induced bronchodilation in patients with stable COPD.
    Cazzola M; Santus P; D'Adda A; Pizzolato S; Di Marco F; Centanni S
    Pulm Pharmacol Ther; 2009 Jun; 22(3):177-82. PubMed ID: 19038356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventilation-perfusion response after fenoterol in hypoxemic patients with stable COPD.
    Viegas CA; Ferrer A; Montserrat JM; Barberà JA; Roca J; Rodriguez-Roisin R
    Chest; 1996 Jul; 110(1):71-7. PubMed ID: 8681669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Tsukino M; Mishima M; Izumi T
    Thorax; 1996 Jan; 51(1):48-53. PubMed ID: 8658369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparing the bronchodilating effects of ipratropium bromide and theophylline].
    Dai L; Li X; Yang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Oct; 21(10):609-11. PubMed ID: 11477880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there any difference between effects of ipratropium bromide and formoterol on exercise capacity in moderate COPD patients?
    Akkoca Yildiz O; Onen ZP; Demir G; Eriş Gülbay B; Saryal S; Karabiyikoğlu G
    Tuberk Toraks; 2006; 54(2):105-13. PubMed ID: 16924565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial. COMBIVENT Inhalation Aerosol Study Group.
    Chest; 1994 May; 105(5):1411-9. PubMed ID: 8181328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the effects of salbutamol and ipratropium bromide on exercise endurance in patients with COPD.
    Oga T; Nishimura K; Tsukino M; Sato S; Hajiro T; Mishima M
    Chest; 2003 Jun; 123(6):1810-6. PubMed ID: 12796154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
    Jarvis B; Markham A
    Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of theophylline and ipratropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease.
    Tsukino M; Nishimura K; Ikeda A; Hajiro T; Koyama H; Izumi T
    Thorax; 1998 Apr; 53(4):269-73. PubMed ID: 9741369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute bronchodilator therapy does not reduce wasted ventilation during exercise in COPD.
    Elbehairy AF; Webb KA; Laveneziana P; Domnik NJ; Neder JA; O'Donnell DE;
    Respir Physiol Neurobiol; 2018 Jun; 252-253():64-71. PubMed ID: 29578103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of PAF-induced gas exchange defects by beta-adrenergic agonists in mild asthma is not due to bronchodilation.
    Díaz O; Barberà JA; Marrades R; Chung KF; Roca J; Rodriguez-Roisin R
    Am J Respir Crit Care Med; 1997 Jul; 156(1):17-22. PubMed ID: 9230720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Izumi T
    Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Airway response of horses with COPD to dry powder inhalation of ipratropium bromide.
    Duvivier DH; Votion D; Vandenput S; Art T; Lekeux P
    Vet J; 1997 Sep; 154(2):149-53. PubMed ID: 9308401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The additive effect of theophylline on a high-dose combination of inhaled salbutamol and ipratropium bromide in stable COPD.
    Nishimura K; Koyama H; Ikeda A; Sugiura N; Kawakatsu K; Izumi T
    Chest; 1995 Mar; 107(3):718-23. PubMed ID: 7874943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.